Cargando…

Sex, ApoE4 and Alzheimer’s disease: rethinking drug discovery in the era of precision medicine

Detalles Bibliográficos
Autores principales:	Paranjpe, Manish D., Wang, Jason K, Zhou, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328780/ https://www.ncbi.nlm.nih.gov/pubmed/33510067 http://dx.doi.org/10.4103/1673-5374.306070

Ejemplares similares

Precision Nutrition for Alzheimer’s Prevention in ApoE4 Carriers
por: Norwitz, Nicholas G., et al.
Publicado: (2021)

Immunotherapy in the Precision Medicine Era: Melanoma and Beyond
por: Su, Mack Y., et al.
Publicado: (2016)

Is it time to rethink the Alzheimer's disease drug development strategy by targeting its silent phase?
por: Souchet, Benoit, et al.
Publicado: (2018)

Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer's disease
por: Yan, Shaozhen, et al.
Publicado: (2020)

ApoE2 and Alzheimer's disease: time to take a closer look
por: Wu, Long, et al.
Publicado: (2016)

Cancer prevention and screening: the next step in the era of precision medicine
por: Loomans-Kropp, Holli A., et al.
Publicado: (2019)

Health as activism: rethinking social medicine in India
por: Chakrabarti, Pratik
Publicado: (2022)

Open drug discovery in Alzheimer's disease
por: Axtman, Alison D., et al.
Publicado: (2023)

Applications of Radiomics and Radiogenomics in High-Grade Gliomas in the Era of Precision Medicine
por: Fathi Kazerooni, Anahita, et al.
Publicado: (2021)

The fourth scientific discovery paradigm for precision medicine and healthcare: Challenges ahead
por: Shen, Li, et al.
Publicado: (2021)

Journey from oncologist to cancer survivor and patient advocate in the era of precision medicine
por: Needles, Burton M.
Publicado: (2018)

Precision medicine: Clarity for the clinical and biological complexity of Alzheimer’s and Parkinson’s diseases
por: Montine, Thomas J., et al.
Publicado: (2015)

Rethinking Opsins
por: Feuda, Roberto, et al.
Publicado: (2022)

Drugs for solid cancer: the productivity crisis prompts a rethink
por: Rösel, Daniel, et al.
Publicado: (2013)

Detrimental Effects of ApoE ε4 on Blood–Brain Barrier Integrity and Their Potential Implications on the Pathogenesis of Alzheimer’s Disease
por: Kirchner, Kevin, et al.
Publicado: (2023)

APOE targeting strategy in Alzheimer’s disease: lessons learned from protective variants
por: Bu, Guojun
Publicado: (2022)

Diversity and Inclusion in Drug Development: Rethinking Intrinsic and Extrinsic Factors with Patient Centricity
por: Venkatakrishnan, Karthik, et al.
Publicado: (2021)

Mixed pathologies and neural reserve: Implications of complexity for Alzheimer disease drug discovery
por: Bennett, David A.
Publicado: (2017)

Rethinking 3D-QSAR
por: Cramer, Richard D.
Publicado: (2010)

Implementing Genomic Clinical Decision Support for Drug‐Based Precision Medicine
por: Freimuth, RR, et al.
Publicado: (2017)

Evidence-based medicine and precision medicine: Complementary approaches to clinical decision-making
por: Chow, Ngai, et al.
Publicado: (2018)

Unveiling the Genetic Architecture of Human Disease for Precision Medicine
por: Ramamoorthy, Anuradha, et al.
Publicado: (2018)

Stem cell-derived three-dimensional (organoid) models of Alzheimer’s disease: a precision medicine approach
por: Kim, Sujung Jun, et al.
Publicado: (2021)

Rethinking the INN system for therapeutic antibodies
por: Pottier, Jérémy, et al.
Publicado: (2016)

Rethinking the pathway to sustainable fire retardants
por: Feng, Jiabing, et al.
Publicado: (2023)

Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study
por: Desai, Rishi J., et al.
Publicado: (2020)

Precision cardiovascular medicine in China
por: LIU, Jie, et al.
Publicado: (2020)

Molecular and Genomic Profiling of Lung Cancer in the Era of Precision Medicine: A Position Paper from the Italian Association of Thoracic Oncology (AIOT)
por: Normanno, Nicola, et al.
Publicado: (2020)

Biomarker-guided drug therapy: personalized medicine for treating Alzheimer’s disease
por: Syal, Charvi, et al.
Publicado: (2021)

Why We Need to Rethink the Diseases of Affluence
por: Novotny, Thomas E
Publicado: (2005)

Rethinking Ecosystem Resilience in the Face of Climate Change
por: Côté, Isabelle M., et al.
Publicado: (2010)

Rethinking the approach to viability monitoring in seed genebanks
por: Hay, Fiona R., et al.
Publicado: (2017)

Rethinking Cultural Competence: Shifting to Cultural Humility
por: Lekas, Helen-Maria, et al.
Publicado: (2020)

Rethinking resilience and development: A coevolutionary perspective
por: Haider, L. Jamila, et al.
Publicado: (2021)

Evolution of Next Generation Therapeutics: Past, Present, and Future of Precision Medicines
por: Ramamoorthy, Anuradha, et al.
Publicado: (2019)

Religious Perspectives on Precision Medicine in Singapore
por: Toh, Hui Jin, et al.
Publicado: (2021)

From Personalized Medicine to Precision Psychiatry?
por: Češková, Eva, et al.
Publicado: (2021)

Focusing on optimality for the translation of precision medicine
por: Kahkoska, Anna R., et al.
Publicado: (2022)

Precision medicine: affording the successes of science
por: Lu, Christine Y., et al.
Publicado: (2023)

Sex modifies APOE ε4 dose effect on brain tau deposition in cognitively impaired individuals
por: Yan, Shaozhen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h63n2vpb9e7topg968ir34h3hr